Cybin Inc. (NEO:HELP)
Canada · Delayed Price · Currency is CAD 9.80
-0.35 (-3.45%)
At close: Jan 27, 2026
Cybin Market Cap
Cybin has a market cap or net worth of CAD 483.09 million as of January 29, 2026. Its market cap has increased by 88.30% in one year.
Market Cap
483.09M
Enterprise Value
408.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.80
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from 119.00M to 483.09M, an increase of 305.97%. That is a compound annual growth rate of 30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 483.09M | -13.69% |
| Dec 31, 2025 | 559.71M | 120.51% |
| Dec 31, 2024 | 253.83M | 13.98% |
| Dec 29, 2023 | 222.69M | 192.45% |
| Dec 30, 2022 | 76.15M | -70.67% |
| Dec 31, 2021 | 259.60M | 4.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.14B |
| Eupraxia Pharmaceuticals | 625.51M |
| NervGen Pharma | 519.31M |
| Satellos Bioscience | 231.88M |
| Helix BioPharma | 161.16M |
| ME Therapeutics Holdings | 90.15M |
| Medicenna Therapeutics | 75.08M |
| Sharp Therapeutics | 72.18M |